NIAID Media Roundtable: On the Frontlines
of Flu Research
As concerns about the flu dominate the headlines, please
join us as Anthony S. Fauci, M.D., NIAID director, briefs
the media about frontline laboratory and clinical research,
- future technologies for the development and manufacture
of vaccines, including reverse genetics, cell-culture techniques
and recombinant proteins
- NIAID-supported clinical trials to study herd immunity
and the head-to-head efficacy of different vaccines
- new diagnostic techniques for rapidly detecting avian
flu strains in the event of a pandemic
The event will also serve to launch NIAID’s updated
and expanded Focus on Flu Web site, spotlighting cutting-edge
NIAID-supported research and graphics that illuminate concepts
important to understanding influenza research such as reverse
genetics and antigenic shift and drift.
Following the briefing, Dr. Fauci and other NIAID staff
will take questions from the audience.
Anthony S. Fauci, M.D., NIAID director
Brian Murphy, M.D., co-chief, NIAID Laboratory of Infectious
Kanta Subbarao, M.D., senior investigator, Respiratory
Viruses Section, NIAID Laboratory of Infectious Diseases
Linda Lambert, Ph.D., acting chief, NIAID Division of
Microbiology and Infectious Diseases (DMID), Influenza,
SARS, and Related
Cristina Cassetti, Ph.D., program officer, NIAID DMID
Influenza, SARS, and Related Viral Respiratory Diseases
Giovanni, Ph.D., chief, NIAID DMID Genomics and Technology
||Monday, Nov. 15, 10:30 - 11:30 a.m. Eastern Time
||NIH Campus, Natcher Conference Center, Room E1/E2 Bethesda, MD
Attendees are strongly encouraged to use the Metro. The NIH campus can be easily accessed via the Medical Center stop on the Metro’s Red Line. For information on transportation to and parking and security at NIH, go to http://www.nih.gov/about/visitorsecurity.htm.
||Advanced registration is requested. To register, contact Jennifer Wenger or Laurie K. Doepel at (301) 402-1663, or e-mail email@example.com. Individuals with disabilities who need Sign Language Interpreters or reasonable accommodation to participate in this roundtable should contact Jennifer Wenger or Laurie K. Doepel. Such requests should be made at least 5 days in advance of the event.
NIAID is a component of the National Institutes of Health,
an agency of the U.S. Department of Health and Human Services.
NIAID supports basic and applied research to prevent, diagnose
and treat infectious diseases such as HIV/AIDS and other sexually
transmitted infections, influenza, tuberculosis, malaria and illness
from potential agents of bioterrorism. NIAID also supports research
on transplantation and immune-related illnesses, including autoimmune
disorders, asthma and allergies.
Press releases, fact sheets and other NIAID-related materials
are available on the NIAID Web site at http://www.niaid.nih.gov.